Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Nanomedicine. 2013 Jun 28;10(1):10.1016/j.nano.2013.06.010. doi: 10.1016/j.nano.2013.06.010

Table 3.

Study Population Comprehensive Metabolic Panel and Complete Blood Count with Differential (10 ppm [n=36], 32 ppm [n=24], Total Sample [n=60])

Comprehensive Metabolic
Panel and
Complete Blood Cell
Count with Differential
10 ppm
Mean Change
[95% CI: min, max] (p
value)
32 ppm
Mean Change
[95% CI: min, max] (p
value)
Total Sample
Mean Change
[95% CI: min, max] (p
value)
Sodium [mmol/L] −0.1[−0.7, 0.6] (0.87) 0.2 [−0.7, 1.0] (0.71) 0.03 [−0.5, 0.6] (0.90)
Potassium [mmol/L] −0.1[−0.3, 0.02] (0.10) −0.03 [−0.2, 0.1] (0.74) −0.08 [−0.2, 0.03] (0.13)
Chloride [mmol/L] −0.4[−1.2, 0.3] (0.23) 0.04[−1.1, 1.2] (0.94) −0.3[−0.9, 0.4] (0.44)
Carbon Dioxide [mmol/L] 0.5[−0.5, 1.6] (0.33) −0.04[−1.1, 1.0] (0.94) 0.3[−0.5, 1.1] (0.44)
BUN* [mg/dL] −0.9[−1.7, −0.1] (0.03)** 0.5 [−0.08, 1.8] (0.41) −0.3 [−1.1, 0.4] (0.37)
Creatinine [mg/dL] 0.01 [−0.02, 0.03] (0.60) −0.02 [−0.04, 0.01] (0.21) −0.003 [−0.02, 0.01] (0.74)
Glucose [mg/dL] 3.6 [−1.6, 8.7] (0.17) −0.7 [−4.2, 2.9] (0.71) 1.9 [−1.5, 5.3] (0.28)
ALP [U/L] −1.4 [−3.9, 1.1] (0.28) 2.0 [−1.0, 5.0] (0.18) −0.03 [−2.0, 1.9] (0.97)
AST [U/L] −0.44 [−2.1, 1.2] (0.60) 2.0 [−2.6, 6.5] (0.40) 0.5 [−1.5, 2.5] (0.61)
ALT [U/L] −2.6 [−4.8, −0.3] (0.03)** 2.3 (−1.6, 6.3) (0.25) −0.6 (−2.7, 1.5) (0.58)
Total Protein [g/dL] −0.02 [−0.3, 0.2] (0.87) 0.2 [−0.001, 0.4] (0.051) 0.1 [−0.1, 0.3] (0.45)
Total Bilirubin [mg/dL] −0.02 [−0.08, 0.3] (0.43) −0.03 [−0.11, 0.05] (0.49) −0.02 [−0.07, 0.02] (0.29)
Albumin [g/dL] −0.07 [−0.1, 0.0004) (0.06) 0.11 [−0.01, 0.23] (0.09) 0.002 [−0.07, 0.07] (0.96)
Calcium [mg/dL] −0.1 [−0.2, 0.04] (0.20) 0.1 [−0.003, 0.2] (0.06) 0.0 [−0.1, 0.1] (0.99)
WBC Count [k/μL] −0.17 [−0.53, 0.19] (0.35) −0.09 [−0.68, 0.49] (0.75) −0.14 [−0.46, 0.17] (0.38)
RBC Count [M/μL] −0.08 [−0.17, −0.001]
(0.047)**
0.06 [−0.03, 0.14] (0.23) −0.03 [−0.09, 0.03] (0.37)
Hemoglobin [gm/dL] −0.2 [−0.4, 0.03] (0.08) 0.1 [−0.2, 0.4] (0.41) −0.1 [−0.3, 0.1] (0.41)
Hematocrit [%] −0.7 [−1.5, 0.07] (0.075) 0.8 [−0.1, 1.7] (0.095) −0.1 [−0.8, 0.5] (0.68)
MCV [fL] 0.1 [−0.6, 0.8] (0.80) 0.5 [−0.1, 1.2] (0.12) 0.3 [−0.2, 0.7] (0.29)
MCH [pg] 0.1 [−0.1, 0.3] (0.48) −0.1 [−0.4, 0.2] (0.38) −0.01 [−0.2, 0.2] (0.96)
MCHC [gm/dL] 0.1 [−0.3, 0.4] (0.72) −0.3 [−0.7, 0.1] (0.12) −0.1 [−0.3, 0.2] (0.53)
Platelets [k/μL] 5 [−6, 15] (0.39) −4 [−16, 8] (0.53) 1.3 [−6.8, 9.4] (0.76)
Granulocytes [%] −0.9 [−3.0, 1.1] (0.36) −0.7 [−4.0, 2.7] (0.70) −0.9 [−2.8, 1.0] (0.36)
Lymphocytes [%] 0.7 [−1.2, 2.6] (0.46) 1.3 [−1.5, 4.1] (0.36) 1.0 [−0.8, 2.7] (0.27)
Monocytes [%] −0.1 [−0.6, 0.4] (0.70) −0.3 [−0.8, 0.3] (0.34) −0.2 [−0.5, 0.2] (0.38)
Basophils [%] 0.04 [−0.1, 0.2] (0.58) 0.001 [−0.1, 0.1] (0.99) −0.02 [−0.1, 0.1] (0.61)
Eosinophils [%] −0.06 [−0.3, 0.2] (0.69) −0.2 [−0.7, 0.2] (0.36) −0.1 [−0.4, 0.1] (0.35)
*

BUN- Blood Urea Nitrogen; ALP: Alkaline Phosphatase; AST: Aspartate Aminotransferase; ALT: Alanine Aminotransferase; WBC: White Blood Cells; RBC: Red Blood Cells; MCV: Mean Corpuscular Volume; MCH: Mean Corpuscular Hemoglobin; MCHC: Mean Corpuscular Hemoglobin Concentration.

**

p≤0.05 Comparison of 10 ppm or 32 ppm active solution vs. placebo solution, controlling for baseline value, in a mixed effects linear regression model.